Multiomics Reveals Distinct Immune-Metabolic Dysfunction in Preeclampsia Subtypes
Single-cell analysis identifies unique cellular signatures in early vs late-onset preeclampsia, with serum biomarkers enabling early prediction.
Summary
Researchers used advanced single-cell and spatial analysis techniques to study placental tissue from women with early-onset and late-onset preeclampsia. They discovered that these two forms of the pregnancy disorder involve distinct cellular and metabolic dysfunction patterns. Early-onset preeclampsia showed increased immune cells and disrupted oxygen transport, while late-onset disease had stronger inflammatory responses but preserved cellular structure. The team also identified three blood metabolites that could predict early-onset preeclampsia with over 85% accuracy during early pregnancy.
Detailed Summary
Preeclampsia affects 8% of pregnancies worldwide and poses serious risks to both mothers and babies. This pregnancy disorder has two main forms: early-onset (before 34 weeks) and late-onset (after 34 weeks), but scientists haven't fully understood how these subtypes differ at the cellular level.
Researchers analyzed placental tissue from women with both forms of preeclampsia using cutting-edge single-cell RNA sequencing, spatial transcriptomics, and metabolomics. They also studied blood samples from 199 pregnant women to identify early warning signs. The team identified 14 different cell types in the placenta, with particular focus on Hofbauer cells (placental immune cells) and trophoblasts (cells crucial for nutrient exchange).
The results revealed striking differences between preeclampsia subtypes. Early-onset preeclampsia showed increased numbers of immune cells and trophoblasts, along with reduced oxygen-transporting cell populations. These placentas had disrupted oxygen transport and heightened stress response pathways. In contrast, late-onset preeclampsia maintained normal cellular composition but exhibited stronger inflammatory gene expression programs and disrupted immune signaling.
Most importantly, the researchers identified three blood metabolites—phosphatidylcholine PC(22:5/0:0), 3-hydroxybutyric acid, and L-allothreonine—that could predict early-onset preeclampsia with over 85% accuracy when measured during early pregnancy (10-13 weeks). This finding could enable earlier intervention and better pregnancy management.
These discoveries provide crucial insights into why preeclampsia subtypes behave differently and offer a potential path toward personalized pregnancy care. The identified biomarkers could help doctors identify high-risk pregnancies much earlier than current methods allow, potentially improving outcomes for both mothers and babies.
Key Findings
- Early-onset preeclampsia shows increased immune cells and disrupted oxygen transport pathways
- Late-onset preeclampsia preserves cellular structure but has stronger inflammatory responses
- Three blood metabolites predict early-onset preeclampsia with >85% accuracy at 10-13 weeks
- Hofbauer cells and trophoblasts undergo distinct dysfunction patterns in each subtype
- Spatial analysis reveals subtype-specific metabolic disruptions in placental regions
Methodology
Study used single-cell RNA sequencing, spatial transcriptomics, and spatial metabolomics on placental tissues from 8 pregnancies (EOPE, LOPE, and controls), plus untargeted serum metabolomics from 199 women in early pregnancy. Advanced computational methods identified cell types, signaling pathways, and predictive biomarkers.
Study Limitations
Study conducted entirely in Asian population which may limit generalizability. Small sample size for placental analysis (8 cases total). Prospective multicenter validation needed to confirm biomarker performance and functional validation required for identified cellular pathways.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.